Melanotan II Linked to Kidney Blood Flow Blockage in Case Report

Case report of a single patient who developed renal infarction in the setting of Melanotan II use, combined with a literature review of Melanotan II's known effects on the kidneys.

Melanotan II is widely available through unregulated online markets and used by thousands of people for tanning and sexual enhancement, despite never being approved for human use by any regulatory agency. Most users are unaware of serious risks like kidney damage. This case report adds renal infarction — a potentially life-threatening condition — to the growing list of documented harms. It also highlights that renal infarction is frequently misdiagnosed or diagnosed late, meaning the actual incidence in Melanotan II users may be higher than reported.

Melanotan II represents a broader problem: unregulated peptides sold directly to consumers who use them without medical supervision. As the peptide market grows, so does the documentation of serious adverse events. This case adds to a pattern of kidney-related harms from Melanotan II and underscores the need for public awareness about the risks of self-administering research peptides.

This is a single case report, which cannot prove causation — only an association between Melanotan II use and renal infarction. The patient may have had other risk factors not fully described. The exact mechanism of injury remains hypothetical. Case reports represent the lowest level of clinical evidence.